prior part the SAFETXT:A randomised controlled of target the an intervention delivered by mobile phone take completed screened messaging to reduce sexually transmitted 85 30 115 No patients to meeting Yes recruit infections (STI) by increasing sexual health enrolment offered were Neither No none 103581 188241 deadline precaution behaviours in young people consented 27/05/2017 09/11/2016 01/02/2017 27/04/2016 01/02/2017 27/04/2017 28/04/2017 - 15/LO/1665 first G and online the Patients criteria opportunity to however the A Phase 4 open-label randomized to a has can controlled study COmparing the Trust issues effectiveness of adalimumab iNTROduction 34 No we Principal Staff No notice recruiting therefore provider Prinicipal the and methotrexate dose escaLation in - 103582 210762 E to participants, are subjects with Psoriatic Arthritis 23/05/2016 29/03/2017 10/02/2017 11/04/2017 02/05/2017 03/05/2017 arranging commence 16/SC/0615 recruitment NHS Investigator The before given we leave any prior availability investigator suitable CARMS: A psychological intervention for suicide applied to patients with psychosis: 14 27 41 Yes Yes the CARMS trial 103583 201644 21/06/2017 23/02/2017 11/05/2017 11/05/2017 06/03/2017 25/05/2017 25/05/2017 17/NW/0089 who Within in Managing Adolescent first episode 42 70 inclusion Psychosis: a feasibility Study No patients days seen Neither criteria 103584 209020 the no Difficulty 13/03/2017 26/04/2017 09/02/2017 10/04/2017 07/06/2017 08/06/2017 identifying 16/NW/0893 F- participants meet
103581 15/LO/1665 188241 SAFETXT:A randomised controlled of an intervention delivered by mobile phone messaging to reduce sexually transmitted infections (STI) by increasing sexual health precaution behaviours in young people Yes 27/05/2017 85 30 115 No 09/11/2016 01/02/2017 27/04/2016 01/02/2017 27/04/2017 28/04/2017 G - No patients consented Patients meeting the criteria were screened and offered the opportunity to take part however none completed the online enrolment prior to the first recruit target deadline Neither 103582 16/SC/0615 210762 A Phase 4 open-label randomized controlled study COmparing the effectiveness of adalimumab iNTROduction and methotrexate dose escaLation in subjects with Psoriatic Arthritis No 34 No 23/05/2016 29/03/2017 10/02/2017 11/04/2017 02/05/2017 03/05/2017 E - Staff availability issues The Prinicipal investigator has given notice to leave the Trust prior to recruiting any participants, we are therefore arranging a suitable Principal Investigator before we can commence recruitment NHS provider 103583 17/NW/0089 201644 CARMS: A psychological intervention for suicide applied to patients with psychosis: the CARMS trial Yes 21/06/2017 14 27 41 Yes 23/02/2017 11/05/2017 11/05/2017 06/03/2017 25/05/2017 25/05/2017 103584 16/NW/0893 209020 Managing Adolescent first episode Psychosis: a feasibility Study No 42 Within 70 days 13/03/2017 26/04/2017 09/02/2017 10/04/2017 07/06/2017 08/06/2017 F- no patients seen Difficulty in identifying participants who meet the inclusion criteria Neither
Performance%20in%20Initiating%20Research%20-%20Q1%202017-18.docx